Key result
Upregulated AGT expression is linked to ~62% higher mortality in stomach adenocarcinoma.
Why the study?
The angiotensinogen gene (AGT) has been linked to various malignancies, but little is known about its relationship to clinicopathological data and overall survival.
Observational
In this bioinformatics pan-cancer analysis, angiotensinogen gene (AGT) expression was associated with clinicopathological features in gastrointestinal cancers and predicted shorter overall survival in stomach adenocarcinoma but longer survival in clear cell renal carcinoma.
Answers are grounded in this paper and cite their sources.
Elevated AGT expression was associated with shorter survival in stomach adenocarcinoma; leaves open its value as a prognostic biomarker pending prospective validation.
Angiotensinogen gene (AGT) has been linked to various malignancies; however, little is known about its relationship to the clinicopathological data and survival rate. This study aimed to assess the association of AGT expression with the clinicopathological data and overall survival in various malignancies. Comprehensive pan-cancer analysis was performed across 33 tumors using TIMER, GEPIA, and UALCAN databases. Then, cancers that displayed significant and concordant results in the three databases were selected for further analysis. Accordingly, our results showed significantly higher AGT expression in colorectal adenocarcinoma (COAD), rectum adenocarcinoma (READ), and stomach adenocarcinoma (STAD) tumors than in normal tissue (p < 0.001); however, AGT expression was significantly lower in kidney chromophobe (KICH) tumors compared with the normal (p < 0.001). The AGT expression was significantly associated with clinicopathological data in patients with COAD, READ, and STAD. Furthermore, the AGT expression was significantly correlated with immune cell recruitment in COAD and STAD. In survival analysis, upregulated AGT expression in STAD patients was significantly linked to shorter overall survival (Kaplan–Meier HR = 1.62; CI = 1.17–2.25; p < 0.001) (GEPIA: HR = 1.5, p = 0.02). In contrast, AGT overexpression was significantly associated with longer overall survival in patients with kidney renal clear cell carcinoma (KIRC) (Kaplan–Meier: HR = 0.66; CI = 0.48–0.89; p = 0.01) (GEPIA: HR = 0.66, p = 0.01). In conclusion, AGT expression is associated with the clinicopathological features in COAD, READ, and STAD. Furthermore, AGT expression is linked to the overall survival of STAD and KIRC patients. An experimental study is required to confirm our findings.
No takes yet. Share an insight, caveat, or question.
Osman et al. (2026) conducted an observational in Multiple cancers (33 tumor types including colorectal, rectum, stomach adenocarcinoma, and kidney carcinomas). Angiotensinogen gene (AGT) expression vs. Normal tissue or lower AGT expression was evaluated on Overall survival in stomach adenocarcinoma (STAD) (HR 1.62, 95% CI 1.17-2.25, p=<0.001). Upregulated AGT expression was linked to shorter overall survival in stomach adenocarcinoma and longer survival in KIRC.
Synapse has enriched 10 related papers. Consider them for comparative context: